UC MSTP graduate and Merck Senior Scientist, Reshma Rangwala, was featured in The New York Times on a Merck-sponsored page...“Our researchers are working to invent new ways to fight cancer – and ultimately, to find a cure.” (Merck Pharmaceuticals)

Read about Dr. Rangwala's discoveries in the New England Journal of Medicine: 
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. 
Pembrolizumab for the treatment of non-small-cell lung cancer.